It is non-pyrogenic and isotonic, supporting osmotic conditions compatible with many research preparations
Most users begin with 0.25 mg once daily to assess tolerance before potentially increasing
Your doctor may arrange investigations including a full blood count, serum folate levels, and in some cases, anti-intrinsic factor antibodies if pernicious anaemia hasn't been previously confirmed
Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer
In more focused areas, such as clinical-style trial design, bodybuilding research, or gender-specific studies, it offers clarity and precision